NASACORT AQ NASAL SPRAY 55 mcgactuation

Country: Singapore

Language: English

Source: HSA (Health Sciences Authority)

Active ingredient:

TRIAMCINOLONE ACETONIDE

Available from:

OPELLA HEALTHCARE SINGAPORE PTE. LTD.

ATC code:

R01AD11

Dosage:

55mcg

Pharmaceutical form:

SPRAY

Composition:

TRIAMCINOLONE ACETONIDE 55 mcg/actuation

Administration route:

NASAL

Prescription type:

Prescription Only

Manufactured by:

RECIPHARM HC LIMITED

Authorization status:

ACTIVE

Authorization date:

1999-03-19

Patient Information leaflet

NASACORT®AQ 
_triamcinolone acetonide _
_ _
Nasal Spray 

sanofi aventis 
NASACORT®AQ 
[na’ za-cort] 
(triamcinolone acetonide) 
Nasal Spray 
For intranasal use only. 
Shake Well Before Using 

DESCRIPTION 
Triamcinolone acetonide, USP, the active ingredient in Nasacort® AQ Nasal Spray, is a 
corticosteroid with a molecular weight of 434.51 and with the chemical designation 9-
Fluoro-11ß,16 α, 17,21-tetrahydroxypregna-1, 4-diene-3, 20-dione cyclic 16, 17- acetal 
with acetone (C
24
H
31
FO
6
). 

NASACORT AQ Nasal Spray is an unscented, thixotropic, water-based metered-dose pump 
spray formulation unit containing a microcrystalline suspension of triamcinolone 
acetonide in an aqueous medium. Microcrystalline cellulose, carboxymethylcellulose 
sodium, polysorbate 80, dextrose, benzalkonium chloride, and edetate disodium are 
contained in this aqueous medium; hydrochloric acid or sodium hydroxide may be added 
to adjust the pH to a target of 5.0 within a range of 4.5 and 6.0.  
Each actuation delivers 55 mcg triamcinolone acetonide from the nasal actuator after an 
initial priming of 5 sprays. It will remain adequately primed for 2 weeks. If the product is 
not used for more than 2 weeks, then it can be adequately reprimed with one spray. The 
contents of one 6.5 gram bottle provide 30 actuations, and the contents of one 16.5 gram 
bottle provide 120 actuations. AFTER EITHER 30 ACTUATIONS OR 120 ACTUATIONS, THE AMOUNT 
OF TRIAMCINOLONE ACETONIDE DELIVERED PER ACTUATION MAY NOT BE CONSISTENT AND THE 
UNIT SHOULD BE DISCARDED. Each 30 actuation bottle contains 3.575 mg of triamcinolone 
acetonide and each 120 actuation bottle contains 9.075 mg of triamcinolone acetonide. 
In the Information for Patients, patients are provided with a 

Summary of Product characteristics

SG/NAS/0622/SmPC1121
NASACORT
® AQ
[na’ za-cort]
(triamcinolone acetonide)
Nasal Spray
For intranasal use only.
Shake Well Before Using
DESCRIPTION
Triamcinolone acetonide, USP, the active ingredient in NASACORT
® AQ Nasal Spray, is a corticosteroid with a
molecular weight of 434.51 and with the chemical designation
9-Fluoro-11ß,16 α,17,21-tetrahydroxypregna-1, 4-
diene-3, 20-dione cyclic 16, 17- acetal with acetone (C
24
H
31
FO6).
NASACORT AQ Nasal Spray is an unscented, thixotropic, water-based
metered-dose pump spray formulation unit
containing a microcrystalline suspension of triamcinolone acetonide in
an aqueous medium. Microcrystalline
cellulose,
carboxymethylcellulose
sodium,
polysorbate
80,
dextrose,
benzalkonium
chloride,
and
edetate
disodium are contained in this aqueous medium; hydrochloric acid or
sodium hydroxide may be added to adjust
the pH to a target of 5.0 within a range of 4.5 and 6.0.
Each actuation delivers 55 mcg triamcinolone acetonide from the nasal
actuator after an initial priming of 5 sprays.
It will remain adequately primed for 2 weeks. If the product is not
used for more than 2 weeks, then it can be
adequately reprimed with one spray. The contents of one 6.5 gram
bottle provide 30 actuations, and the contents
of one 16.5 gram bottle provide 120 actuations. AFTER EITHER 30
ACTUATIONS OR 120 ACTUATIONS, THE AMOUNT OF
TRIAMCINOLONE ACETONIDE DELIVERED PER ACTUATION MAY NOT BE CONSISTENT
AND THE UNIT SHOULD BE DISCARDED.
Each 30 actuation bottle contains 3.575 mg of triamcinolone acetonide
and each 120 actuation bottle contains
9.075 mg of triamcinolone acetonide.
In the Information for Patients, patients are provided with a checkoff
form to track usage.
INDICATIONS AND USAGE
NASACORT AQ Nasal Spray is indicated for the treatment of the nasal
symptoms of seasonal and perennial
allergic rhinitis in adults and children 4 years of age and older.
CONTRAINDICATIONS
Hypersensitivity to any of the ingredients of this preparation
contraindicates its use.
SPECIAL WARNINGS AND PRECAUTION FOR